What is Pyramid Pharma Services?
PYRAMID Laboratories, Inc., operating as Pyramid Pharma Services, is a specialized provider of contract manufacturing and analytical services tailored for the pharmaceutical and biotechnology sectors. The company focuses on parenteral drug product manufacturing, a critical and complex area of pharmaceutical development. Its services are essential for companies seeking to bring innovative therapies to market, offering expertise in both production and rigorous quality control.
How much funding has Pyramid Pharma Services raised?
Pyramid Pharma Services has raised a total of $2.3M across 2 funding rounds:
Debt
$1M
Debt
$1.3M
Debt (2020): $1M with participation from PPP
Debt (2021): $1.3M led by PPP
What's next for Pyramid Pharma Services?
The substantial enterprise-level funding suggests Pyramid Pharma Services is poised for significant expansion. This capital injection will likely be directed towards enhancing manufacturing capacity, investing in advanced analytical technologies, and potentially broadening its service portfolio to meet the evolving demands of the biopharmaceutical industry. The company's strategic focus on parenteral drug products positions it to capitalize on the growing market for injectable and infusible therapies, further solidifying its role as a key partner in drug development and commercialization.
See full Pyramid Pharma Services company page
